Molecular diversity
Exploring the impacts of flavonoid compounds on escitalopram metabolism: a combined in vitro and in vivo study.
Hailun Xia, Jun Wu, Haoxin Fu, Peiqi Wang, Ruibin Li, Lu Cao, Ya-Nan Liu, Lu Shi, Ren-Ai Xu
Published: 202610.1007/s11030-025-11439-5
Abstract
Escitalopram, a selective serotonin reuptake inhibitor (SSRI), treats depression and related anxiety symptoms by enhancing the physiological effects of serotonin (5-HT). This study explored the potential drug-drug interactions (DDIs) of combining esc…
Preview only. Read the full abstract at the source